Jeremy P. Bond

Associate

Jeremy Bond’s practice involves drafting and prosecuting patents, portfolio database development, and technical analysis to assist with strategic advisory and legal opinion matters.

Before joining Finnegan, Mr. Bond was a senior member of an intellectual property consulting firm where he led the Medical Devices Group. His work included analysis of competitor patent portfolios and products in support of litigations and due diligence projects. He also has considerable experience related to comprehensive IP landscapes and strategic consulting. Mr. Bond’s consulting projects focused on minimally invasive medical devices, cardiac technologies, and vascular devices, and also included mass spectrometry, DNA chips, and proteomic technologies.

While an undergraduate, Mr. Bond developed computer-based models of two-stroke combustion processes. During his graduate work, Mr. Bond studied the fiber structures of beta-sheet forming peptides, including betabellin, amyloid-beta, and prion proteins.

Professional Activities

• American Intellectual Property Law Association
• Boston Patent Law Association

Select Publications

• "Billion dollar patents?" MassDevice, Oct. 20, 2010.
• First author. "Assemblies of Alzheimer’s Peptides AB(25-35) AB(31-35): Reverse-turn Conformation and Side Chain Interactions Revealed by X-ray Diffraction," Journal of Structural Biology, 2003.
• Coauthor. "Molecular Organization of Amyloid Protofilament-like Assembly of Betabellin 15D: Helical Array of Beta-Sandwiches," Biophysical Journal, 2002.
• First author. "Expression and Purification of the Extracellular Domain of Human Myelin Protein Zero," Protein Expression and Purification, 2001.
• Coauthor. "Betabellins 15D and 16D, De Novo Designed Beta-Sandwich Proteins That Have Amyloidogenic Properties," Journal of Structural Biology, 2000.
• Coauthor. "Structural Changes in a Conserved Hydrophobic Domain of the Prion Protein Induced by Hydration and by Ala->Val and Pro->Leu Substitutions," Journal of Molecular Biology, 2000.
• First author. "Spinal Cord Myelin is Vulnerable to Decompression," Molecular and Chemical Neuropathology, 1997.